Predict Before You Test
The Future of Drug Development Is Predictive
Mechanistic modeling and quantitative science for confident decisions across the drug development lifecycle.
KinetiX brings formulation science, translational pharmacology, PBPK and virtual bioequivalence into one clear decision environment, helping teams move from complex biological evidence to confident development strategy.
Development Workflow
From experimental signal to regulatory decision.
Reference Product Understanding
Define the QTPP, analyze the reference product, and map the clinical and biopharmaceutical target.
API & Excipient Characterization
Characterize physicochemical properties, solid state, permeability, solubility, and excipient risks.
Formulation & Dissolution Design
Develop prototype formulations and generate discriminative dissolution data across relevant conditions.
In Vitro Performance Mapping
Integrate dissolution, permeability, precipitation, and stability data to understand product behavior.
PBPK / PBBM Model Development
Build mechanistic absorption and disposition models linking formulation attributes to in vivo exposure.
IVIVC / IVIVR & Sensitivity Analysis
Quantify in vitro-in vivo relationships and identify critical variables driving exposure and bioequivalence.
Virtual Bioequivalence Simulations
Test formulation scenarios, batch variability, population variability, and BE risk before clinical studies.
Study Design & Regulatory Strategy
Optimize the BE study design or support a biowaiver strategy with model-based scientific justification.
Submission, Decision & Lifecycle Management
Translate evidence into regulatory decisions, dossier support, post-approval changes, and knowledge reuse.
Kinetix Software Ecosystem
Build the future of predictive drug development with us.
We are creating scientific software, consulting systems and modeling workflows that make advanced drug development intelligence more accessible.
Explore careers